Literature DB >> 31997061

Impact of atrial fibrillation on frailty and functionality in older adults.

Meltem Koca1, Burcu Balam Yavuz2, Rana Tuna Doğrul2, Hatice Çalışkan2, Gözde Şengül Ayçiçek2, Cemile Özsürekçi2, Cafer Balcı2, Mert Eşme2, Pelin Ünsal2, Meltem Halil2, Mustafa Cankurtaran2.   

Abstract

BACKGROUND AND AIM: Atrial fibrillation (AF), the most common sustained arrhythmia in older adults, causes significant complications such as stroke, dementia, and decreased quality of life. Frailty is a geriatric syndrome that is associated with increased risk of poor clinical outcomes including falls, disability, and mortality. We aimed to investigate the relationship between AF and frailty and functionality in older adults.
METHODS: A total of 123 patients 64 with AF and 59 with normal sinus rhythm were enrolled in the study with cross-sectional design. All patients underwent comprehensive geriatric assessment (CGA). Frailty status was assessed using Fried criteria and FRAIL scale. The brief Older People's Quality of Life questionnaire was applied for quality of life. Results of the laboratory tests were recorded and compared for both groups.
RESULTS: Although the frequency of frailty status determined by the Fried criteria and the FRAIL scale was higher in the AF group, this difference was not statistically significant. However, it was found that there was a positive correlation between the European Heart Rhythm Association (EHRA) AF symptom score and frailty according to the FRAIL scale (Goodman and Kruskal gamma coefficient = 0.39, p = 0.020). Comorbidities and polypharmacy were more common in the AF group (p < 0.001, both). CGA revealed lower Lawton-Brody Instrumental Activities of Daily Living scores (p = 0.024), higher fall rates in the previous year (p = 0.016), and slower walking speed (p = 0.020) in the AF group. Total cholesterol, LDL, HDL, total protein, albumin, and prealbumin were lower; brain natriuretic peptide (BNP) and C-reactive protein (CRP) levels were higher in the AF group.
CONCLUSIONS: EHRA AF symptom severity score is positively correlated with frailty. AF is associated with worse metabolic profile and clinical features on CGA that AF might be a frailty marker. Frailty should be investigated in AF patients.

Entities:  

Keywords:  Atrial fibrillation; Comprehensive geriatric assessment; EHRA symptom score; FRAIL scale; Frailty; Quality of life in elderly

Year:  2020        PMID: 31997061     DOI: 10.1007/s11845-020-02190-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  5 in total

1.  A case-control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

2.  Cardiovascular Health in Individuals with Exceptional Longevity Residing in Arkansas.

Authors:  Brandi M Mize; Brandon Duke; Amanda K Pangle; Jeanne Y Wei; Gohar Azhar
Journal:  Gerontol Geriatr Med       Date:  2021-05-26

3.  Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study.

Authors:  Emilia Salvadori; Francesco Galmozzi; Francesca Uda; Carmen Barbato; Eleonora Camilleri; Francesca Cesari; Stefano Chiti; Stefano Diciotti; Samira Donnini; Benedetta Formelli; Silvia Galora; Betti Giusti; Anna Maria Gori; Chiara Marzi; Anna Melone; Damiano Mistri; Francesca Pescini; Giovanni Pracucci; Valentina Rinnoci; Cristina Sarti; Enrico Fainardi; Rossella Marcucci; Anna Poggesi
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

4.  Self-Reported Walking Pace and Risk of Cardiovascular Diseases: A Two-Sample Mendelian Randomization Study.

Authors:  Lu Chen; Xingang Sun; Yuxian He; Liangrong Zheng
Journal:  Front Genet       Date:  2022-06-16       Impact factor: 4.772

5.  Understanding the Burden of Atrial Fibrillation and Importance of Screening: A Global Perspective and Recommendations for Turkey.

Authors:  Dursun Aras; Erdem Birgül; Bülent Görenek; Erdem Gürkaş; Atilla Özcan Özdemir; Mehmet Akif Topçuoğlu; Erdinç Yavuz; Mehdi Zoghi
Journal:  Anatol J Cardiol       Date:  2022-09       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.